The mean duration of stay in hospital for patients undergoing abdominal hysterotomy was 101 days. The average stay after aspiration and laparoscopic sterilization was 2-4 days, the shortest being nine hours. In this latter group the mean age of the patients was 32-6-syears and the average number of children 3-5.
Termination of Pregnancy-Steptoe and Imran MEDICf=mNAL
The mean duration of stay in hospital for patients undergoing abdominal hysterotomy was 101 days. The average stay after aspiration and laparoscopic sterilization was 2-4 days, the shortest being nine hours. In this latter group the mean age of the patients was 32-6-syears and the average number of children 3-5.
Complications occurred in only seven cases of the series, and there were no maternal deaths. The details of these complications are as follows:
Three cases of chronic nephritis and one case of mitral valve disease developed mild pyrexia, and were treated with penicillin.
One case of incomplete aspiration of the uterus needed a repeat evacuation of retained products, blood transfusion, and antibiotics.
One case required readmission because of a pelvic abscess; this was drained through a posterior colpotomy incision.
One case had damage to vessels of the mesosalpinx which was not readily controlled, and laparotomy was immediately performed with suture of the damaged vessels.
As a rule antibiotics were not prescribed without first taking swabs from the cervix and vagina for bacteriological examination, identification, and sensitivity. In the pyrexial cases the urine was also examined for possible infection as a routine. Blood grouping and haemoglobin estimations were also carried out in all cases. The amount of blood loss was always measured. Blood transfusion was used in only two patients in whom the preoperative haemoglobin level was below 73 %.
The criteria for choosing to carry out the procedures on a day-patient basis were the absence of a complicating medical disease or signs of pelvic infection, the presence of a preoperative haemoglobin of 80%, and no occurrence of any complication during the operation. The procedure should be carried out only where full hospital facilities are available, and where preparation for a laparotomy has previously been made. The day cases received atropine 0 6 mg. only half an hour before operation. A short-acting general anaesthetic was always used, and full resuscitation facilities and equipment were available in a large recovery bay next to the theatre which could accommodate six patients. Intramuscular ergometrine 0 5 mg. was given half an hour before discharge to the patient's home. The patient's general practitioner was informed of the proposed plan of discharge from the hospital, and was also contacted during the morning of the operation on the day patients.
In these circumstances it is believed that this combined procedure has a definite place in the gynaecological repertory, being safe, economic in usage of beds, and without disturbance of patients (Steptoe, 1969 report the development of chronic lymphocytic leukaemia in a third sibling and carrier of the abnormal chromosome.
The revised pedigree of the C. family, with further information on the inheritance of Ch', is shown in Fig. 1 There can be little doubt from these results that Chl is one of the earlier G chromosomes to complete D.N.A. replication (Fig. 2) . If structural change has not altered the normal labelling behaviour of this chromosome, and there is no evidence of this in the overall autoradiographic data, Chl is a G, chromosome and therefore different from the later labelling G,, which is trisomic in Down's syndrome (Schmid, 1963 ; German, 1964; Yunis et al., 1965 ; Fraccaro et al., 1967) , and which also appears to be involved in the Ph' abnormality of chronic granulocytic leukaemia (Schmid, 1963 (Fitzgerald et al., 1966, and unpublished) . Visible chromosomal abnormalities are not a general factor determining familial leukaemia.
Thirdly, there is no evidence of Chl or similar abnormalities in more than 70 cases of chronic lymphocytic leukaemia examined in this laboratory (Fitzgerald and Adams, 1965, and unpublished) and in several patients examined by others (Oppenheim et al., 1965; Lawler et al., 1968) . Inherited or acquired cytogenetic abnormalities of a visible size are not significant in the aetiology of chronic lymphocytic leukaemia as a whole, though it is possible that changes of a smaller magnitude are involved (Fitzgerald, 1965) .
Fourthly, other reports of inherited chromosomal abnormalities similar in appearance to Chl show no association with leukaemia. We know of 10 such reports in which the abnormal chromosomes were associated either with Down's syndrome (Shaw, 1962 ; Ito and Makino, 1966 ; Neu et al., 1966) or with a wide range of defects involving bone, muscle, and heart (Migeon, 1965; Mutton and Gross, 1965 ; Abbott, 1966; Elmore et al., 1966; Neu et al., 1966; Pfeiffer, 1966; Subrt and BrychniZ, 1966) . In many of these families the abnormal chromosome was also present in normal persons. Autoradiographic identification of the abnormal chromosomes was not mentioned in any of these reports. In some families the G2 chromosome will not be involved, and this is particularly the case where the chromosomal abnormality was associated with Down's syndrome, and an effect on non-disjunction of chromosome G1 might be expected. In families having a G2 abnormality the absence of leukaemia could be due to a different nature of the cytogenetic change, such as a different position of breakage or translocation, or to the absence of other factors which. are present in the C. family and which are necessary for the development of leukaemia.
Fifthly, the identification of Chl as a G2 chromosome makes it clear that Chl does not involve a chromosome already known to be associated with leukaemia-namely, the trisomy of G1 in Down's syndrome and Ph' in chronic myeloid leukaemia.
These considerations offer little support for the case that Ahl has a role in leukaemogenesis. At the same time they do not establish the opposing view, and do not detract from the possible importance of Chl as a predisposing factor to leukaemia in the C. family, and therefore of general interest in leukaemic aetiology. Clearly Chl cannot be the sole factor determining leukaemia in this family, because leukaemia is not an immediate, nor possibly even a certain, consequence of its presence, though follow-up studies on other carriers should clarify this point. If Chl is concerned with leukaemia it must be one of a number of changes or factors which together lead to the development of the disease, and as such would readily be included in a multifactorial system of carcinogenesis (Burch, 1962 (Burch, , 1963 .
